Prof. Erika Lietzan

Professor Lietzan to Attend Economics Institute for Law Professors

May 17th, 2017

Professor Erika Lietzan was selected to attend the Thirty-Third Economics Institute for Law Professors, hosted by the Henry G. Manne Program in Law and Economic Studies at the Antonin Scalia Law School at George Mason University. Professor

Read More

Professor Lietzan Files Amicus Brief with U.S. Supreme Court in Patent Case

March 24th, 2017

Professor Lietzan recently filed an amicus brief in the United States Supreme Court, in a closely-watched case involving patent litigation under the Biologics Price Competition and Innovation Act (BPCIA). The appellate court concluded that biosimilar applicants may

Read More

Professor Lietzan Quoted on Selection of FDA Commissioner

March 23rd, 2017

Professor Erika Lietzan was recently quoted in BuzzFeed News regarding President Donald Trump’s selection of Dr. Scott Gottlieb to be the next commissioner of the U.S. Food & Drug Administration. Dr. Gottlieb was deputy commissioner under President

Read More

Citizen Petitions at the FDA: Professor Lietzan Interviewed by The Atlantic

March 20th, 2017

Professor Erika Lietzan was recently interviewed by a reporter for The Atlantic in connection with the use of “citizen petitions” at the U.S. Food & Drug Administration (FDA). A recent article in the New England Journal of

Read More

Professor Lietzan Quoted on “Right to Try” Legislation

March 17th, 2017

Professor Erika Lietzan was recently quoted in numerous papers around the country in connection with possible federal “right to try” legislation. Broadly speaking, the purpose of state “right to try” laws is to make it possible for

Read More